Medicaid Spending on GLP-1 Drugs by State Nationally, Medicaid spending on GLP-1s totaled $3.5 billion between November 2023 and October 2024, averaging $48 per Medicaid enrollee
Burg D, Riepsaame J, Pont C, Mulder G, van de Water B
Global, Regional, and National Comparative Risk Assessment of 79 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks, 1990-2015: A Systematic Analysis for the Global Burden of Disease Study 2015
GLP-1 medication-related constipation is different from regular constipation
Interestingly, -oxidation and aerobic glycolysis are connected to each other through cross-signaling in such a manner that beta-oxidation not only is compatible with ongoing aerobic glycolysis, but also it promotes the Warburg Effect